University of Iowa · Microbiology & ImmunologyHIV Resistance and Antiviral Strategies Lab
Hillel Haim · Iowa City, Iowa
Research Focus
Dr. Hillel Haim's lab focuses on understanding how HIV-1 can develop resistance to therapeutic treatments. The research aims to personalize medicine for HIV patients by predicting which viruses are likely to escape treatment. By studying the virus's genetic properties and how they change over time, the lab works towards developing strategies for more effective antiviral therapies.
HIV-1personalized medicineantiviral therapytherapeutic resistancebroadly neutralizing antibodies
Research Aims
5AIM 01Investigate the likelihood of HIV-1 developing resistance to therapeutics in individual patients.
AIM 02Analyze the genetic properties of HIV-1 to predict escape from treatments.
AIM 03Test the fitness of viral strains in relation to their resistance profiles.
AIM 04Establish models to forecast patient-specific responses to antiviral agents.
AIM 05Explore the changes in viral fitness profiles over time in HIV-1 patients.
Skills the Lab Values
in vitro testingviral genome analysisdeep sequencingmolecular cloningclinical trial modeling
Output against the department
Publications46bottom 9% of dept.440th of 486
this lab
most publishedleast published
Citations1.4kbottom 8% of dept.447th of 486
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.